Zhengya Gao

Downregulation of miR-7-5p Inhibits the Tumorigenesis of Esophagus Cancer via Targeting KLF4

W. Shi, Jianxiang Song, Zhengya Gao, 2020, OncoTargets and therapy.

Downregulation of circRNA_100876 Inhibited Progression of NSCLC In Vitro via Targeting miR-636

W. Shi, Jianxiang Song, Zhengya Gao, 2020, Technology in cancer research & treatment.

Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group

S. Donaldson, D. Rodeberg, D. Hawkins, 2022, Pediatric blood & cancer.

Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children's Oncology Group

W. Xue, P. Lupo, R. Venkatramani, 2023, Cancer medicine.

Outcomes following preoperative chemoradiation +/- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): A report from Children's Oncology Group (COG) and NRG Oncology.

Jessica L. Davis, R. Randall, S. Spunt, 2022, Journal of Clinical Oncology.

Analysis of gene expression profiles of non-small cell lung cancer at different stages reveals significantly altered biological functions and candidate genes.

Shiying Zheng, Jianxiang Song, Yajun Zhang, 2017, Oncology reports.

Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee

D. Rodeberg, W. Xue, R. Venkatramani, 2023, Pediatric blood & cancer.

Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group

D. Harrison, R. Venkatramani, A. Weiss, 2024, Pediatric blood & cancer.